166 related articles for article (PubMed ID: 38508544)
1. A comprehensive review on role of Aurora kinase inhibitors (AKIs) in cancer therapeutics.
Gupta D; Kumar M; Saifi S; Rawat S; Ethayathulla AS; Kaur P
Int J Biol Macromol; 2024 Apr; 265(Pt 2):130913. PubMed ID: 38508544
[TBL] [Abstract][Full Text] [Related]
2. Identification of polypharmacological anticancerous molecules against Aurora kinase family of proteins.
Gupta D; Kumar M; Singh M; Salman M; Das U; Kaur P
J Cell Biochem; 2022 Apr; 123(4):719-735. PubMed ID: 35040172
[TBL] [Abstract][Full Text] [Related]
3. Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer.
Sankhe K; Prabhu A; Khan T
Chem Biol Drug Des; 2021 Jul; 98(1):73-93. PubMed ID: 33934503
[TBL] [Abstract][Full Text] [Related]
4. Regulation of spindle and chromatin dynamics during early and late stages of oocyte maturation by aurora kinases.
Swain JE; Ding J; Wu J; Smith GD
Mol Hum Reprod; 2008 May; 14(5):291-9. PubMed ID: 18353803
[TBL] [Abstract][Full Text] [Related]
5. Aurora kinases in ovarian cancer.
Pérez-Fidalgo JA; Gambardella V; Pineda B; Burgues O; Piñero O; Cervantes A
ESMO Open; 2020 Oct; 5(5):e000718. PubMed ID: 33087400
[TBL] [Abstract][Full Text] [Related]
6. Aurora B Inhibitors as Cancer Therapeutics.
Kovacs AH; Zhao D; Hou J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110619
[TBL] [Abstract][Full Text] [Related]
7. Switching of INCENP paralogs controls transitions in mitotic chromosomal passenger complex functions.
Feng H; Raasholm M; Moosmann A; Campsteijn C; Thompson EM
Cell Cycle; 2019 Sep; 18(17):2006-2025. PubMed ID: 31306061
[TBL] [Abstract][Full Text] [Related]
8. Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.
Stefani A; Piro G; Schietroma F; Strusi A; Vita E; Fiorani S; Barone D; Monaca F; Sparagna I; Valente G; Ferrara MG; D'Argento E; Di Salvatore M; Carbone C; Tortora G; Bria E
Front Oncol; 2022; 12():1026020. PubMed ID: 36387232
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mitotic phosphorylation of borealin.
Kaur H; Stiff AC; Date DA; Taylor WR
BMC Cell Biol; 2007 Jan; 8():5. PubMed ID: 17241471
[TBL] [Abstract][Full Text] [Related]
10. Influence of different pH milieu on the structure and function of human Aurora kinase B protein (AURK-B): Amalgamation of both spectroscopic and computational approach.
Gupta D; Kumari R; Kumar M; Singh M; Rawat S; Ethayathulla AS; Kaur P
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 312():124047. PubMed ID: 38394881
[TBL] [Abstract][Full Text] [Related]
11. Aurora B: a new prognostic marker and therapeutic target in cancer.
Portella G; Passaro C; Chieffi P
Curr Med Chem; 2011; 18(4):482-96. PubMed ID: 21143115
[TBL] [Abstract][Full Text] [Related]
12. The Aurora kinases: role in cell transformation and tumorigenesis.
Katayama H; Brinkley WR; Sen S
Cancer Metastasis Rev; 2003 Dec; 22(4):451-64. PubMed ID: 12884918
[TBL] [Abstract][Full Text] [Related]
13. Aurora kinase inhibitors in preclinical and clinical testing.
Cheung CH; Coumar MS; Hsieh HP; Chang JY
Expert Opin Investig Drugs; 2009 Apr; 18(4):379-98. PubMed ID: 19335272
[TBL] [Abstract][Full Text] [Related]
14. Aurora-B kinase inhibitors for cancer chemotherapy.
Yeung SC; Gully C; Lee MH
Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation modulates the function of Aurora-B kinase.
Fernández-Miranda G; Pérez de Castro I; Carmena M; Aguirre-Portolés C; Ruchaud S; Fant X; Montoya G; Earnshaw WC; Malumbres M
J Cell Sci; 2010 Aug; 123(Pt 16):2823-33. PubMed ID: 20663916
[TBL] [Abstract][Full Text] [Related]
16. The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis.
Vazquez-Martin A; Oliveras-Ferraros C; Menendez JA
Cell Cycle; 2009 Aug; 8(15):2385-98. PubMed ID: 19556893
[TBL] [Abstract][Full Text] [Related]
17. Targeting aurora kinases in cancer treatment.
Kelly KR; Ecsedy J; Mahalingam D; Nawrocki ST; Padmanabhan S; Giles FJ; Carew JS
Curr Drug Targets; 2011 Dec; 12(14):2067-78. PubMed ID: 21777198
[TBL] [Abstract][Full Text] [Related]
18. Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10).
Cheung CH; Coumar MS; Chang JY; Hsieh HP
Expert Opin Ther Pat; 2011 Jun; 21(6):857-84. PubMed ID: 21591849
[TBL] [Abstract][Full Text] [Related]
19. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.
Li JJ; Li SA
Pharmacol Ther; 2006 Sep; 111(3):974-84. PubMed ID: 16603252
[TBL] [Abstract][Full Text] [Related]
20. Advances in Aurora kinase inhibitor patents.
Coumar MS; Cheung CH; Chang JY; Hsieh HP
Expert Opin Ther Pat; 2009 Mar; 19(3):321-56. PubMed ID: 19441907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
